Home > Insider Trading > Filing (0001193805-21-001123)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882361	Aptose Biosciences Inc.	APTO	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1535383	Drw Holdings, Llc	540 W. Madison St. Suite 2500 Chicago IL 60661	No	No	Yes	No
1565352	Jr. R. Donald Wilson	540 W. Madison St., Suite 2500 Chicago IL 60661	No	No	Yes	No
1566768	Drw Commodities, Llc	540 W. Madison St., Suite 2500 Chicago IL 60661	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-03	57,199	$2.65	8,948,275	No	4	P	Indirect	Through DRW Investments, LLC
Common Stock	Disposition	2021-08-05	60,000	$2.62	8,888,275	No	4	S	Indirect	Through DRW Investments, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Through DRW Investments, LLC
No	4	S	Indirect	Through DRW Investments, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,162	Indirect	Through DRW Commodities, LLC

Footnotes

The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.64 to $2.65, inclusive. The Reporting Persons (as defined below) undertake to provide to Aptose Biosciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
This Form 4 is being filed by the undersigned Donald R. Wilson Jr. ("Wilson"), as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Wilson is the sole manager of each of DRW Investments, LLC ("DRW Investments"), DRW Commodities, LLC ("DRW Commodities") and DRW Holdings, LLC ("DRW Holdings"). DRW Holdings owns 100% of the outstanding equity of each of DRW Commodities and DRW Investments. A majority of the equity of DRW Holdings is owned, directly or indirectly, by trusts for the benefit of members of Wilson's immediate family and of which Wilson serves as trustee or investment advisor.
Each of the Reporting Persons disclaims beneficial ownership of any securities held by DRW Commodities or DRW Investments, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.